Granules India Limited (BOM:532482)

India · Delayed Price · Currency is INR

783.75

+26.95 (3.56%)

At close: May 27, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Pharmaceutical Products	53.66B	44.82B	45.06B	45.12B	37.65B
Pharmaceutical Products Growth	19.73%	-0.55%	-0.12%	19.84%	16.29%
Total	53.66B	44.82B	45.06B	45.12B	37.65B
Total Growth	19.73%	-0.55%	-0.12%	19.84%	16.29%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
India	2.71B	2.26B	2.90B	4.56B
India Growth	20.06%	-22.09%	-36.55%	0.68%
Outside India	42.11B	42.81B	42.22B	33.09B
Outside India Growth	-1.64%	1.38%	27.62%	-
Total	44.82B	45.06B	45.12B	37.65B
Total Growth	-0.55%	-0.12%	19.84%	15.14%

Source: S&P Global Market Intelligence.